Catalyst4, Inc., 10% Owner at MapLight Therapeutics, Inc. (MLPT), bought 19,697,464 shares at $17.00 ($92.5M) on 2025-10-28, disclosed to the SEC on 2025-10-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 14,256,288 | $0 | 0.0% |
| 2 | $17.00 | 5,441,176 | $92.5M | 100.0% |
| Total | $4.70 avg | 19,697,464 | $92.5M | 100% |
| Filing → |